Binding model for eriodictyol to Jun-N terminal kinase and its anti-inflammatory signaling pathway
- PMID: 24195792
- PMCID: PMC4133860
- DOI: 10.5483/bmbrep.2013.46.12.092
Binding model for eriodictyol to Jun-N terminal kinase and its anti-inflammatory signaling pathway (V体育官网)
Abstract
The anti-inflammatory activity of eriodictyol and its mode of action were investigated. Eriodictyol suppressed tumor necrosis factor (mTNF)-α, inducible nitric oxide synthase (miNOS), interleukin (mIL)-6, macrophage inflammatory protein (mMIP)-1, and mMIP-2 cytokine release in LPS-stimulated macrophages. We found that the anti-inflammatory cascade of eriodictyol is mediated through the Toll-like Receptor (TLR)4/CD14, p38 mitogen-activated protein kinases (MAPK), extracellular-signal-regulated kinase (ERK), Jun-N terminal kinase (JNK), and cyclooxygenase (COX)-2 pathway. Fluorescence quenching and saturation-transfer difference (STD) NMR experiments showed that eriodictyol exhibits good binding affinity to JNK, 8. 79 × 10(5) M(-1). Based on a docking study, we propose a model of eriodictyol and JNK binding, in which eriodictyol forms 3 hydrogen bonds with the side chains of Lys55, Met111, and Asp169 in JNK, and in which the hydroxyl groups of the B ring play key roles in binding interactions with JNK VSports手机版. Therefore, eriodictyol may be a potent anti-inflammatory inhibitor of JNK. .
Figures




References
"V体育2025版" Publication types
MeSH terms
- "V体育2025版" Actions
- VSports - Actions
- Actions (V体育平台登录)
- Actions (V体育平台登录)
- "V体育官网" Actions
- "V体育平台登录" Actions
- Actions (V体育ios版)
- V体育官网 - Actions
- Actions (V体育2025版)
- VSports app下载 - Actions
Substances (V体育安卓版)
- "V体育ios版" Actions
- "VSports" Actions
- Actions (V体育官网)
"V体育2025版" LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous